Skip to ContentSkip to Navigation
About us Latest news News News articles

The development of novel biodegradable polymeric biomaterials for use in the repair of damaged intervertebral discs

10 December 2012

PhD ceremony: Mr. S. Sharifi, 12.45 uur, Academiegebouw, Broerstraat 5, Groningen

Dissertation: The development of novel biodegradable polymeric biomaterials for use in the repair of damaged intervertebral discs

Promotor(s): prof. D.W. Grijpma

Faculty: Medical Sciences

Low back pain (LBP) affects a considerable proportion of the population in Western industrialized countries. Intervertebral disc (IVD) injuries, either small fissures in the outer part of IVD (annulus fibrosus) or protrusions of the inner part of IVD (nucleus pulposus) through a failing annulus fibrosus, are the main causes of back pain. Current treatments for LBP include conservative therapy and surgery. These therapies are complicated, not functional and only alleviate symptoms. New therapies for LBP are based on regenerative medicine and tissue engineering. These therapies aim to restore disc function by reversing the degeneration process or engineering new healthy tissue. Novel strategies for annular repair are compulsory for the success of these treatments. This thesis addresses biomaterial-based strategies for securely sealing a herniated disc (torn annulus fibrosus) and integrating a tissue engineering construct to native annulus fibrosus tissue. Four different classes of resorbable biomaterials were developed and characterized, i.e., shape memory polymers, injectable and photo-crosslinkable macromers, reinforced nanocomposite hydrogels and polymeric tissue adhesives. In parallel, the potential of these biomaterials for closure of annulus fibrosus were investigated. Results of this work have highlighted the complexity and multifactorial aspect of LBP. We have shown some of the main challenges in developing strategies and materials for immediate restoration of IVD stability after herniation. These findings can help researchers to design more efficient biomaterials based systems for low back pain treatment.

Last modified:13 March 2020 01.01 a.m.
View this page in: Nederlands

More news

  • 27 August 2024

    UMCG gaat onderzoeksfaciliteiten beschikbaar stellen voor geneesmiddelenontwikkeling

    Om de beschikbaarheid en effectiviteit van geneesmiddelen in Nederland te verbeteren gaat het UMCG het bedrijf G² Solutions opzetten. Dit bedrijf moet ervoor gaan zorgen dat belangrijke technologische ontwikkelingen op het gebied van DNA sequencing...

  • 17 July 2024

    Veni-grants for ten researchers

    The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to ten researchers of the University of Groningen and the UMCG. The Veni grants are designed for outstanding researchers who have recently gained a PhD.

  • 16 July 2024

    Medicine still subjects to male bias

    Aranka Ballering studied the course of illness in people with common symptoms. One of the most striking findings to emerge from her research was that on average, women have a different – and less extensive – course of illness than men.